32 pending office actions • 19 clients • 30 examiners • 20 art units • 0 of 32 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (9%) |
| §103 only | 6 (19%) |
| §102 only | 1 (3%) |
| §112 only | 2 (6%) |
| Double-patenting + other | 6 (19%) |
| Multi-statute (no §101) | 14 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WEBB, WALTER E | 2 | 46.5% | +18.6% |
| MARTIN, KEVIN STEPHEN | 2 | 75.7% | +24.4% |
| MOAZZAMI, NAGHMEH NINA | 1 | 73.1% | +41.9% |
| BEHARRY, ZANNA MARIA | 1 | 23.2% | +52.7% |
| STEINKE, SEAN JAMES | 1 | 12.5% | +42.9% |
| STRANSKY, KATRINA MARIE | 1 | 74.1% | +24.5% |
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.5% |
| BARRON, SEAN C | 1 | 53.3% | +30.6% |
| BLANCHETTE, JOSHUA B | 1 | 47.6% | +31.0% |
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18502426 | ELECTRICAL CONDITION DATA MANAGEMENT APPARATUS, PROGRAM, AND METHOD | BLANCHETTE, JOSHUA B | 91d overdue |
| 17799466 | A PROCESS FOR THE PRODUCTION OF A BAKED PRODUCT WITHOUT ADDITION OF SUGAR | TRAN, LIEN THUY | 73d overdue |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | MARTIN, KEVIN STEPHEN | 31d overdue |
| 17999081 | Use of SAA, rSAA or inhibitors of SAA in the treatment of dysregulated inflammation | JUEDES, AMY E | 17d overdue |
| 18250643 | Anti-Microbial Skin-Care Composition Comprising Beta-Glucan and Natural Oil | WEBB, WALTER E | 15d overdue |
| 18354129 | COSMETIC COMPOSITION | SCOTLAND, REBECCA LYNN | 4d overdue |
| 18836116 | Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte | BEHARRY, ZANNA MARIA | — |
| 18705154 | A Three-Dimensional Scaffold for Medical Use Comprising Animal Collagen | STEINKE, SEAN JAMES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18502426 | ELECTRICAL CONDITION DATA MANAGEMENT APPARATUS, PROGRAM, AND METHOD | BLANCHETTE, JOSHUA B | 91d overdue |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | MARTIN, KEVIN STEPHEN | 31d overdue |
| 17438158 | Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders | MARTIN, KEVIN STEPHEN | 31d overdue |
| 17939570 | Liquid Composition for Cleaning, Sanitizing and/or Disinfecting | WEBB, WALTER E | 26d overdue |
| 18250643 | Anti-Microbial Skin-Care Composition Comprising Beta-Glucan and Natural Oil | WEBB, WALTER E | 15d overdue |
| 18904277 | Method for Preparing a Three-Dimensional Scaffold for Medical Use | MOAZZAMI, NAGHMEH NINA | — |
| 18836116 | Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte | BEHARRY, ZANNA MARIA | — |
| 18705154 | A Three-Dimensional Scaffold for Medical Use Comprising Animal Collagen | STEINKE, SEAN JAMES | — |
| Art Unit | Apps |
|---|---|
| 1655 | 2 |
| 1653 | 2 |
| 1612 | 2 |
| 1624 | 2 |
| 1793 | 2 |
| 1651 | 2 |
| 1657 | 2 |
| 1619 | 1 |
| 3684 | 1 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18904277 | Method for Preparing a Three-Dimensional Scaffold for Medical Use | Askel Heathcare Ltd. | MOAZZAMI, NAGHMEH NINA | §103DP | Non-Final OA | — | Pending | Oct 02, 2024 | |
| 18836116 | Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte | The Jikei University | BEHARRY, ZANNA MARIA | §102§112 | Non-Final OA | — | Pending | Aug 06, 2024 | |
| 18705154 | A Three-Dimensional Scaffold for Medical Use Comprising Animal Collagen | Askel Healthcare Ltd. | STEINKE, SEAN JAMES | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18705215 | A PLA-COLLAGEN SCAFFOLD FOR MEDICAL USE LOADED WITH CELLS | Askel Healthcare Ltd. | STRANSKY, KATRINA MARIE | §102§103§112DP | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18702300 | Composition for Promoting the Assimilation of an Oligosaccharide | Morinaga Milk Industry Co., Ltd. | HOFFMAN, SUSAN COE | 1655 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18631361 | BACTERIUM MODIFIED TO EXPRESS HETEROLOGOUS Tat PROTEIN | Ajinomoto Co., Inc. | BARRON, SEAN C | §102§103 | Non-Final OA | — | Pending | Apr 10, 2024 | |
| 18502426 | ELECTRICAL CONDITION DATA MANAGEMENT APPARATUS, PROGRAM, AND METHOD | Ajinomoto Co., Inc. | BLANCHETTE, JOSHUA B | 3684 | §101§103 | Non-Final OA | 91d overdue | Pending | Nov 06, 2023 |
| 18354129 | COSMETIC COMPOSITION | Ajinomoto Co., Inc. | SCOTLAND, REBECCA LYNN | 1615 | §103 | Final Rejection | 4d overdue | Pending | Jul 18, 2023 |
| 18354140 | COSMETIC COMPOSITION | Ajinomoto Co., Inc. | SAEED, ALI S | 1616 | §103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18351225 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | Evolva SA | MEAH, MOHAMMAD Y | 1652 | §102§103§112DP | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | Danstar Ferment AG | KOROTCHKINA, LIOUBOV G | 1653 | §103§112DP | Non-Final OA | 49d overdue | Pending | Jul 12, 2023 |
| 18270073 | JUDGMENT SUPPORTING INFORMATION GENERATING METHOD, JUDGMENT SUPPORTING INFORMATION GENERATING SYSTEM, AND INFORMATION PROCESSING DEVICE | Mcbi Inc. | FUELLING, MICHAEL | §101§103§112 | Non-Final OA | — | Pending | Jun 28, 2023 | |
| 18338927 | SOLID CATALYST COMPOSITION FOR ORGANIC WASTE TREATMENT, MANUFACTURING METHOD THEREOF AND USE THEREOF | Tetanti Agribiotech Inc. | MCCLAIN, STARFARI TESHAWN | 1736 | §103 | Non-Final OA | 84d | Pending | Jun 21, 2023 |
| 18256080 | Prebiotic Composition for Butyric Acid Bacteria | Morinaga Milk Industry Co., Ltd. | GALSTER, SAMUEL LEONARD | 1693 | §102 | Final Rejection | 70d overdue | Pending | Jun 06, 2023 |
| 18250643 | Anti-Microbial Skin-Care Composition Comprising Beta-Glucan and Natural Oil | Lantmännen Oats AB | WEBB, WALTER E | 1612 | §103§112 | Final Rejection | 15d overdue | Pending | Apr 26, 2023 |
| 18246797 | Use of Antcin H and Its Derivatives for Treating Central Nervous System Diseases | Alps Biotech Co., Ltd. | LEE, WILLIAM Y | 1623 | §103§112 | Non-Final OA | — | Pending | Mar 27, 2023 |
| 18170671 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME | National Yang Ming Chiao Tung University | GRABER, JAMES J | 1631 | §102§112DP | Final Rejection | 12d | Pending | Feb 17, 2023 |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | Collaborative Medicinal Development, LLC | MARTIN, KEVIN STEPHEN | 1624 | §102§112 | Non-Final OA | 31d overdue | Pending | Jan 17, 2023 |
| 18152377 | Novel Asphalt Binder Additive Compositions and Methods of Use | Collaborative Aggregates, LLC | MERKLING, SALLY ANNE | 1738 | §102§103 | Non-Final OA | — | Pending | Jan 10, 2023 |
| 17999081 | Use of SAA, rSAA or inhibitors of SAA in the treatment of dysregulated inflammation | Lika Antisepsis Gbr | JUEDES, AMY E | 1644 | §103§112 | Final Rejection | 17d overdue | Pending | Nov 17, 2022 |
| 18048519 | Method For Producing Soy Sauce-Like Seasoning | Ajinomoto Co., Inc. | MCCLAIN, TYNESHA L. | 1793 | §102§103§112 | Non-Final OA | — | Pending | Oct 21, 2022 |
| 17910175 | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity | LANTMÄNNEN FUNCTIONAL FOODS AB | FIEBIG, RUSSELL G | 1655 | §103 | Non-Final OA | 35d overdue | Pending | Sep 08, 2022 |
| 17939570 | Liquid Composition for Cleaning, Sanitizing and/or Disinfecting | Corticalis AS | WEBB, WALTER E | 1612 | §103 | Final Rejection | 26d overdue | Pending | Sep 07, 2022 |
| 17799466 | A PROCESS FOR THE PRODUCTION OF A BAKED PRODUCT WITHOUT ADDITION OF SUGAR | Lantmännen Unibake Holding A/S | TRAN, LIEN THUY | 1793 | §103§112 | Non-Final OA | 73d overdue | Pending | Aug 12, 2022 |
| 17831877 | METHOD FOR PRODUCING PEPTIDE HAVING PHYSIOLOGICAL ACTIVITY, AND PEPTIDE COMPRISING SHORT LINKER | Ajinomoto Co., Inc. | MONSHIPOURI, MARYAM | 1651 | §103§112 | Non-Final OA | — | Pending | Jun 03, 2022 |
| 17714537 | Modified Phenylalanine Dehydrogenase | Ajinomoto Co., Inc. | ZINGARELLI, SANDRA | 1653 | §112 | Non-Final OA | 232d overdue | Pending | Apr 06, 2022 |
| 17688035 | COMPOSITION, PRODUCTION METHOD FOR PRODUCING THE SAME, AND METHOD OF PREVENTING CAKING | Morinaga Milk Industry Co., Ltd. | CURRENS, GRANT CARSON | 1651 | §103§112 | Non-Final OA | — | Pending | Mar 07, 2022 |
| 17563532 | METHOD OF TREATING GLIOBLASTOMA | Lantmännen As-Faktor AB | FISCHER, JOSEPH | 1658 | §103§112DP | Non-Final OA | — | Pending | Dec 28, 2021 |
| 17611312 | COMPOSITION | Morinaga Milk Industry Co., Ltd. | EDWARDS, JESSICA FAYE | 1657 | §103 | Non-Final OA | 5d | Pending | Nov 15, 2021 |
| 17480792 | METHOD FOR PRODUCING ALLOLACTOSE | Ajinomoto Co., Inc. | BREEN, KIMBERLY CATHERINE | 1657 | §103§112 | Non-Final OA | — | Pending | Sep 21, 2021 |
| 17438158 | Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders | Collaborative Medicinal Development, LLC | MARTIN, KEVIN STEPHEN | 1624 | §112Other | Non-Final OA | 31d overdue | Pending | Sep 10, 2021 |
| 17193092 | Consumable Product Comprising Malted Dehulled Oats | LANTMÄNNEN FUNCTIONAL FOODS AB | KIM, BRYAN | 1792 | §103§112 | Final Rejection | — | Pending | Mar 05, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial